Literature DB >> 4273024

Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.

E J Goetzl, S I Wasserman, I Gigli, K F Austen.   

Abstract

Incubation of human leukocytes with ascorbic acid at neutral pH and at concentrations 10-50 times that of normal blood levels augmented both the in vitro random migration and chemotaxis of the cells by 100-300% without influencing their phagocytic capacity. Enhancement of mobility by ascorbate was evident for isolated neutrophils, eosinophils, and mono-nuclear leukocytes and was independent of the specific chemotactic stimulus. Stimulation by ascorbate of the hexose monophosphate shunt of adherent neutrophils and augmentation by ascorbate of neutrophil mobility had comparable dose-response relationships, could be reversed by washing the cells, and were both suppressed by preincubation of the neutrophils with 6-aminonicotinamide, but not with the neutrophil-immobilizing factor. Glutathione, the proposed intermediate for ascorbate action, similarly stimulated hexose monophosphate shunt activity and enhanced migration. The enhancement in vitro of leukocyte mobility by ascorbate at concentrations found in some normal tissues, therefore, appears to be dependent upon stimulation of the leukocyte hexose monophosphate shunt.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4273024      PMCID: PMC333062          DOI: 10.1172/JCI107620

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.

Authors:  A B Kay; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

2.  Effect of 6-aminonicotinamide on insulin release and C-14 glucose oxidation by isolated pancreatic rat islets: difference between glucose, tolbutamide and aminophylline.

Authors:  H P Ammon; J Steinke
Journal:  Endocrinology       Date:  1972-07       Impact factor: 4.736

3.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility.

Authors:  E J Goetzl; I Gigli; S Wasserman; K F Austen
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

5.  Eosinophil cell separation from human peripheral blood.

Authors:  R P Day
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

6.  A neutrophil chemotactic factor from human C'5.

Authors:  P A Ward; L J Newman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

7.  Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.

Authors:  E J Goetzl; K F Austen
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

8.  A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

Authors:  E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  28 in total

1.  Vitamin E and vitamin C inhibit arachidonate-induced aggregation of human peripheral blood leukocytes in vitro.

Authors:  S Villa; A Lorico; G Morazzoni; G de Gaetano; N Semeraro
Journal:  Agents Actions       Date:  1986-10

2.  Analysis of the linear under-agarose leukocyte chemotaxis assay.

Authors:  C Rothman; D Lauffenburger
Journal:  Ann Biomed Eng       Date:  1983       Impact factor: 3.934

Review 3.  Modulation of human eosinophil polymorphonuclear leukocyte migration and function.

Authors:  E J Goetzl
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

Review 4.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

Review 5.  Host defenses against infection: importance of phagocytic mechanisms from the study of genetic disorders of leukocyte function.

Authors:  R K Root
Journal:  Bull N Y Acad Med       Date:  1982-11

6.  Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.

Authors:  G B Wilson; H H Fudenberg; M T Parise; E Floyd
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

Review 7.  Vitamin C and immunity: an assessment of the evidence.

Authors:  W R Thomas; P G Holt
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

8.  Potentiation and inhibition of migration of human neutrophils by auranofin.

Authors:  J G Elferink; B M de Koster
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

9.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.

Authors:  E J Goetzl; A H Tashjian; R H Rubin; K F Austen
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.